Objective To determine the relationships between pulse wave velocity (PWV), an estimate of arterial distensibility and cardiovascular risk factors.
Introduction
Arterial compliance plays an important role in cardiovascular diseases and an increasing interest is focused on non-invasive measurement of arterial distensibility. Arterial stiffness was positively correlated with age and blood pressure. Conduit vessel stiffening resulted in increased impedance of the aorta, thus leading to an increase in left ventricular mass [1, 2] and an increase in pulse pressure [3] . An association between increased pulse pressure and adverse cardiovascular events has been demonstrated in hypertensive patients and in the general population [4±6] . Also, an association between increased pulse pressure and stroke has been observed in elderly patients with isolated systolic hypertension, independently of the effects of mean blood pressure [7] . However, few data [8] demonstrate that arterial distensibility is actually independently predictive of cardiovascular diseases.
Case±control studies have shown an increase in aortic stiffness after adjustment for age and blood pressure in speci®c populations: subjects with diabetes, hypercholesterolaemia, or end-stage renal disease or in patients with symptomatic cardiovascular disease, stroke or ischaemic heart disease [9±16]. Recently, Lehmann et al. [17] have found in diabetics and/or in patients with vascular disease, a positive relationship between presumed atherosclerotic load (as assessed by the number of cardiovascular risk factors and events) and noninvasively determined aortic stiffening, based on aortic pulse wave velocity measurements. Even if a great number of studies have focused on the fact that arterial stiffness was involved in various cardiovascular diseases, the interest of aortic stiffness measurement, as a non-invasive marker integrating the vascular damages caused by the most common cardiovascular risk factors in the general population, has not yet been assessed. A population-based study was carried out to discuss this question and to determine the relationships between aortic pulse wave velocity, a classical evaluation of arterial distensibility, and cardiovascular risk factors. 
Methods

Population
Subjects aged 35±64 years were selected at random from a cross-sectional study carried out between 1995 and 1997 by the Toulouse MONICA centre (Multinational Monitoring of Trends and Determinants in Cardiovascular Disease ) [18] . Detailed information on the WHO±MONICA Project has been published elsewhere [19±21] . Participants were randomly selected from the electoral rolls. A sample of 1500 subjects living in south-western France was contacted. The overall response rate was 67.6% and 1015 subjects accepted participation in the study.
Authorisation from the appropriate ethics committee (Comite Â Consultatif de Protection des Personnes dans la Recherche Biome Â dicale de Lille) was obtained. Each subject had to complete an informed consent form before the examination.
Questionnaire and anthropometric measurements
The examination was performed in the morning in a medical centre and a blood sample was drawn after an overnight fast. Helped by specially trained medical staff, each subject completed a questionnaire on his/her medical history, drug intake, smoking habits, and alcohol consumption. Alcohol consumption was quanti®ed in g/day, using a 7 day recall method. The de®nition of tobacco consumption was the quantity of tobacco smoked during the subject's lifetime. The number of pack±years was calculated as the number of packs (20 cigarettes per pack) smoked per day, multiplied by the number of years of smoking. Height, weight, waist and hip circumferences were measured. Waist-to-hip ratio and body mass index (BMI)(weight in kg/height in m 2 ) were calculated.
Blood pressure and heart rate measurements
First, in agreement with the British Hypertension Society recommendations, a 5 min rest at least was respected before heart rate and blood pressure were measured [22] . Heart rate and blood pressure were measured twice in a sitting position. Immediately after, femoral pulse wave velocity (PWV) was measured in the supine position and heart rate and blood pressure were measured twice, again in the supine position. Heart rate was counted over 60 s. The ®rst measurements of blood pressure were taken with a Hawksley random-zero sphygmomanometer (Hawksley & Sons Ltd, Sussex, UK) and the second with a standard sphygmomanometer. All the measurements were performed according to this chronology and with no interruption between each action. Blood pressure measurements were performed using cuff size adapted to the subject's arm circumference. Systolic blood pressure (SBP) was determined by the occurrence of repetitive sounds, and diastolic blood pressure (DBP)
by Korotkoff phase V sounds. All measurements were taken to the nearest 2 mmHg. Mean blood pressure was calculated according to the formula MBP [SBP (DBP 3 2)]/3. The average blood pressure and heart rate measured in the supine position were used for the statistical analysis.
Arterial distensibility
Arterial distensibility was assessed by PWV measurement. PWV is a classic index of arterial stiffness. A semi-automatic device was used to measure carotid± femoral PWV [23] : Complior (Garges les Gonesse, France). Pulse wave was recorded using a TY±306 Fukuda pressure sensitive transducer (Fukuda, Tokyo, Japan). Pressure waveforms were digitised. The sample acquisition frequency for carotid±femoral pulse wave velocity was set at 500 Hz. The two pressure waveforms were stored in a memory buffer. A pre-processing system automatically analysed the gain in each waveform and adjusted it for equality of the two signals.
When the quality of the observed pulse waveform on the computer screen was satisfactory, digitisation was suspended and the calculation of the time delay (t) between the two pressure upstrokes was automatically determined by the Complior. This procedure was repeated on 10 different cardiac cycles and the mean value was used in the analysis. The distance covered by the pulse wave was measured on the surface of the body and represented the distance between the two recording sites (D). PWV was automatically calculated as PWV D/t. The validation of this automatic method has already been described [23] .
The repeatability of the method was assessed in 26 subjects using replicated measurements of pulse wave velocity. The pulse wave velocity was measured twice during the examination. Each measurement was performed by two different observers. Subjects were invited for a second examination during the following month. A third pulse wave velocity measurement was caried out by the ®rst observer.
Biological analysis
Plasma total cholesterol and triglycerides were measured by enzymatic methods adapted to a Hitachi 705 analyser (Boehringer Mannheim, Germany). High-density lipoprotein (HDL) cholesterol was measured in the supernatant after sodium phosphotungstate/magnesium chloride precipitation (Boehringer Mannheim). Lowdensity lipoprotein (LDL) cholesterol was determined by the Friedewald formula. Apolipoproteins (apo) A±I and B were quanti®ed by immunonephelometry (Behringwerke, Marburg, Germany). Fasting plasma glucose was measured with a hexokinase-glucose-6-phosphate dehydrogenase method. Fibrinogen was measured in plasma with the Clauss method [24] . To take into account the dilution induced by the anticoagulant factor, the ®brinogen measurements obtained were corrected according to haematocrit value. Plasma FVII activity (FVIIa) was measured by chronometric method and insulin by radioimmunoassay method.
Statistical analysis
Statistical analysis was performed with SAS statistical software release 6.12 (SAS Institute Inc, Cary, North Carolina, USA). Bivariate analysis was made using the chi-square test for categorical variables and one-way ANOVA test for continuous ones. The relationships between PWV and cardiovascular risk factors were ®rst assessed in subjects free of hypolipidaemic, antidiabetic and antihypertensive treatments and then in treated subjects using a general linear model. First, all the parameters signi®cantly associated with PWV in the bivariate analysis were entered into the model but not the haemodynamic factors. Second, haemodynamic factors were included in the model. Since systolic, diastolic and mean blood pressures were closely correlated and, since systolic blood pressure had the highest correlation coef®cient in the univariate analysis, systolic blood pressure was included into the model.
A second analysis was performed among subjects treated for at least one cardiovascular risk factor. An analysis of covariance (ANCOVA) statistical analysis was used to compare mean values of PWV according to the number of treated risk factors after adjustment for age, apolipoprotein B and haemodynamic parameters. Patients treated for two and three risk factors were pooled because of the small number of subjects.
Results
Descriptive sample analysis
The in¯uence of atherogenic factors on arterial stiffness was ®rst assessed in subjects with no antihypertensive, hypolipidaemic and antidiabetic drugs (n 746, 52.6%) and then in patients treated (de®ned by the use of drugs against these risk factors) for hypertension, dyslipidaemia or diabetes (n 247, 51.8%). Characteristics of subjects according to their treatment status are presented in Table 1 . The results concern 993 subjects with complete data for all the variables (22 subjects were excluded because of incomplete data). As expected, levels of PWV, clinical and biological risk factors were higher in treated than in untreated subjects, except for HDL cholesterol. Nevertheless, in the untreated group, the percentage of subjects with high blood cholesterol (25.6%) (de®ned as total cholesterol > 6.4 mmol/l) was close to the percentage of subjects in the treated group (30.8%). On the other hand, the differences in prevalence of high blood pressure (de®ned as systolic > 160 mmHg or diastolic > 95 mmHg) and high blood glucose (de®ned as glycaemia > 7 mmol/l) were more striking between the two groups. The percentage of subjects with high blood pressure was 7.6 and 24.7% and the percentage of subjects with high blood glucose was 2.3 and 13.0% in untreated and treated subjects respectively.
Relationships between PWV and cardiovascular risk factors Subjects not treated for hypertension, dyslipidaemia and diabetes
In bivariate analysis (Table 2) , age, BMI, waist-to-hip ratio, SBP, DBP, mean blood pressure (MBP), HR, alcohol consumption, total cholesterol, LDL-cholesterol, triglycerides, apolipoprotein B and insulinaemia, were positively correlated and HDL cholesterol was negatively correlated (P 0.06) with PWV. The mean of PWV was signi®cantly higher (P , 0.01) in men 9.11 (1.7) m/s than in women 8.38 (1.4) m/s. In the multiple regression analysis (Table 3) , when risk factors, haemodynamic parameters excepted, were used as independent variables, age, triglycerides, insulinaemia were positively correlated with PWV and gender (women versus men) negatively. When clinical, biological and haemodynamic parameters were introduced into the model, gender, age, SBP and HR were the only variables signi®cantly associated with PWV.
Subjects treated with antihypertensive, hypolipidaemic or antidiabetic drugs
In the bivariate analysis (Table 4) , age, waist-to-hip ratio, SBP, DBP, MBP and apolipoprotein B were positively correlated with PWV. No signi®cant difference was observed between genders. The means (SD) of PWV were 9.59 (1.7) m/s and 9.96 (1.9) m/s in women and in men respectively. In the multiple regression analysis (Table 5) , when clinical and biological, haemodynamic parameters excepted, were used as independent variables, age and apolipoprotein were positively associated with PWV. When haemodynamic parameters were introduced into the model, age (P , 0.01), SBP (P , 0.001), HR (P , 0.01) and apoli- poprotein B (P , 0.05) were positively associated with PWV.
In the ANCOVA analysis (Table 6 ), after adjustment for age and apolipoprotein B, mean level of PWV was signi®cantly higher (P , 0.05) among patients treated for at least two risk factors than in patients treated for one risk factor. Even when haemodynamic factors (SBP and HR) had been taken into account, the difference between the two groups remained signi®cant.
Discussion
The in¯uence of pulse pressure on cardiovascular prognosis, has been well-established [4±6] . Since pulse pressure is partly determined by artery stiffness, noninvasive measurement of aortic distensibility might be a relevant tool to assess cardiovascular risk in clinical practice. In the present study, we used PWV, considered as a marker of aortic stiffness [25] . PWV, measuring foot-to-foot transit time in the aorta, provides a simple, reliable, and non-invasive evaluation of aortic stiffness. Recently, it has been demonstrated in patients with end-stage renal disease that carotid±femoral PWV was a potent predictor of cardiovascular mortality [8] . To understand the relationships between aortic stiffness and cardiovascular disease, the in¯uence of cardiovascular risk factors and atheromatous disease on aortic distensibility have been studied. In 1994, Witteman et al. [26] demonstrated, in a population-based cohort of 855 women (prospectively studied), that the progression of atherosclerosis was associated with a decline in diastolic blood pressure. The authors suggested that a decline in DBP indicated that wall stiffening was associated with atherosclerotic progression. Case±control studies [9, 10, 12, 14] conducted among several speci®c populations supporting this hypothesis, have suggested the deleterious in¯uence of cholesterol, renal disease, diabetes mellitus, hyper- 
TC, total cholesterol; LDL, low-density lipoprotein; HDL, high-density lipoprotein; ApoA1, apolipoprotein A1; ApoB, apolipoprotein B; Glyc., glycaemia; Fib., ®brinogen; FVIIa, Plasma FVII antigen, TG, triglycerides ; { computed after log transformation; } Bonferroni adjustment for multiple tests (n 20 including gender comparison). Ã P , 0.05; ÃÃ P , 0.01. SBP, systolic blood pressure; bpm, beats per minute; â, parameter estimate (â coef®cient); SE, standard error. Ã P , 0.05, ÃÃ P , 0.01, ÃÃÃ P , 0.001. tension and obesity on aortic stiffness. Moreover, aortic distensibility impairment has been established in patients with symptomatic cardiovascular diseases such as stroke, transient ischaemic attack and myocardial infarction [11, 15] . However, little is known about the in¯uence of cardiovascular risk factors on arterial distensibility in a population-based sample. Tackling this problem might contribute to assessment of the interest of PWV measurement as a surrogate end-point in epidemiological studies and as a tool in clinical practice to evaluate cardiovascular risk. This population-based study was carried out to determine the relationships between PWV and the main cardiovascular risk factors in a representative sample of the population of HauteGaronne: a region in the south-west of France. To assess the in¯uence of the treatment on diabetes, hypertension and hypercholesterolaemia, patients who received hypotensive, hypolipidaemic or antidiabetic drugs and untreated subjects were analysed separately.
In this present study population, PWV was signi®cantly different between men and women and gender was independently associated with PWV in untreated subjects, whereas no signi®cant difference was observed between gender in treated patients. The distance covered by the pulse wave was assessed by super®cial measurements of the distance between the two transducers: naturally, this measurement was an estimate of the distance covered by the pulse wave. Major differences in body composition of men and women may account for the difference in PWV observed in each sex. On the other hand it has been shown [27] that in pre-menopausal women the distensibility of brachial and femoral arteries was higher than in age-matched men, whereas arterial distensibility in post-menopausal women was similar to that of age-matched men. Thus, higher prevalence of post-menopausal women might account for the lack of relationship between gender and PWV observed in treated patients (54.3 AE 7.6 years old). However, our study was not designed to assess the in¯uence of hormonal status and of hormonal therapy [28, 29] on arterial distensibility and thus this hypothesis was not tested.
In the present study, we found that heart rate was strongly and independently correlated with carotid± femoral PWV. In agreement with these data, it has been shown [30, 31] in anaesthetised rats that acute increases in heart rate were accompanied by reductions in arterial compliance and distensibility. Similar ®nd-ings have been shown in human subjects [32] . Moreover, in humans subjects, it has been found that high heart rate is strongly associated with reduced distension and elevated pulse-wave velocity, even after adjustment for age and blood pressure [33] . Since both arterial distensibility and heart rate have been associated with cardiovascular prognosis, the positive and independent correlation between PWV and HR, observed in our sample of healthy subjects may account for the respective in¯uence of these parameters on cardiovascular diseases. Indeed, it has been recently reported [34] that the association of high heart rate and high pulse pressure, a parameter strongly correlated with arterial stiffness, did not have an additive effect on cardiovascular mortality in men, indicating that cardiovascular risk induced by the combined presence of high heart rate and pulse pressure was lower than expected. The close and independent correlation between PWV and heart rate observed in our sample of healthy subjects may account for these results.
In the untreated group, which was obviously at lower risk than treated patients, gender, age, HR and MBP were independently correlated with PWV while, in patients treated for cardiovascular risk factors, PWV was not only positively associated with haemodynamic parameters, but also with apolipoprotein B. In addition, PWV was lower in patients treated for one cardiovascular risk factor than in patients treated for two or more risk factors. Hence, these results have shown that in the healthy subjects sample of the population, PWV was mainly determined by age and MBP, and did not mirror the in¯uence of metabolic risk factors. In a group with a higher risk, the cumulative in¯uence of treated cardiovascular risk factors was a determinant for arterial stiffness even after adjustment for blood pressure. Since the ranges of metabolic risk factors between treated and untreated subjects were close, it might be suggested that the lack of relationship between metabolic risk factors and PWV in untreated subjects might not be due to a narrow range of these variables. These results underlined the lack of relevant relationship between metabolic risk factors and PWV in presumably healthy subjects. On the other hand, these data were in agreement with a recent study [35] conducted among hypertensive subjects, showing a positive and independent correlation between PWV and cardiovascular risk, assessed by the Framingham heart study investigations. Moreover, in this previous report, it has been found that an independent correlation between atherosclerotic alterations, the number of atherosclerotic sites and the level of PWV. Hence, it could be hypothesised that the extent of atherosclerotic lesions was the confounding factor of the relationship between PWV and the cumulative in¯uence of cardiovascular risk factors in the subgroup at high risk in treated patients.
Our study has some potential limitations. One limitation was the absence of data on arterial structure. Thus, we could not determine the relative in¯uence of arterial wall remodelling on the relationship between cardiovascular risk factors and aortic stiffness. The second limitation was that the study had not been designed to determine the in¯uence of PWV on cardiovascular prognosis. Hence, a potential and independent effect of PWV on cardiovascular prognosis in a representative population remains to be determined. Further prospective population-based studies are needed to support this hypothesis.
Nevertheless, our results issued from the study sample of a French population suggest that, in asymptomatic high-risk patients, PWV might be a useful tool to assess the in¯uence of cardiovascular risk factors on aortic stiffness, even in the presence of antihypertensive, hypolipidaemic or antidiabetic drugs. Since a decrease in arterial distensiblity has been shown to be associated with cardiovascular prognosis in special populations [8, 36] such ®ndings may be relevant for future cardiovascular studies. Moreover these data should be taken into consideration in the interpretation of clinical trials using PWV as a surrogate end-point.
